BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2478320)

  • 1. Diagnostic value of cerebrospinal fluid myelin basic protein in patients with neurological illness.
    Davies L; McLeod JG; Muir A; Hensley WJ
    Clin Exp Neurol; 1987; 24():5-10. PubMed ID: 2478320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of myelin basic protein in the cerebrospinal fluid in neurologic diseases].
    Bürgisser P; Matthieu JM; de Tribolet N; Gautier E
    Schweiz Med Wochenschr; 1982 May; 112(18):643-7. PubMed ID: 6177033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A diagnostic index of active demyelination: myelin basic protein in cerebrospinal fluid.
    Cohen SR; Brooks BR; Herndon RM; McKhann GM
    Ann Neurol; 1980 Jul; 8(1):25-31. PubMed ID: 6157350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of myelin basic protein in cerebrospinal fluid.
    Ohta M; Ohta K
    Expert Rev Mol Diagn; 2002 Nov; 2(6):627-33. PubMed ID: 12465458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin basic protein in the CSF of patients with multiple sclerosis, optic neuritis and various neurological diseases.
    Pavarotti V; Merelli E; De Palma M; Bettelli G; Faglioni P
    Acta Neurol Belg; 1986; 86(5):311-6. PubMed ID: 2433886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive myelin basic protein in cerebrospinal fluid of patients with peripheral neuropathies.
    Cornblath DR; Griffin JW; Tennekoon GI
    Ann Neurol; 1986 Sep; 20(3):370-2. PubMed ID: 2429614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders.
    Whitaker JN; Lisak RP; Bashir RM; Fitch OH; Seyer JM; Krance R; Lawrence JA; Ch'ien LT; O'Sullivan P
    Ann Neurol; 1980 Jan; 7(1):58-64. PubMed ID: 6153879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of cerebrospinal fluid anti-myelin basic protein in patients with multiple sclerosis.
    Warren KG; Catz I
    Ann Neurol; 1986 Jul; 20(1):20-5. PubMed ID: 2427010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
    Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between levels of cerebrospinal fluid myelin basic protein and IgG measurements in patients with multiple sclerosis.
    Warren KG; Catz I
    Ann Neurol; 1985 May; 17(5):475-80. PubMed ID: 2408558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of immunoreactive myelin basic protein peptide (45-89) in cerebrospinal fluid.
    Gupta MK; Whitaker JN; Johnson C; Goren H
    Ann Neurol; 1988 Mar; 23(3):274-80. PubMed ID: 2454068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A correlation between cerebrospinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis patients.
    Warren KG; Catz I
    Ann Neurol; 1987 Feb; 21(2):183-9. PubMed ID: 2435224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination.
    Cohen SR; Herndon RM; McKhann GM
    N Engl J Med; 1976 Dec; 295(26):1455-7. PubMed ID: 995142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitopes of immunoreactive myelin basic protein in human cerebrospinal fluid.
    Whitaker JN; Gupta M; Smith OF
    Ann Neurol; 1986 Sep; 20(3):329-36. PubMed ID: 2429613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis.
    Warren KG; Catz I; Johnson E; Mielke B
    Ann Neurol; 1994 Mar; 35(3):280-9. PubMed ID: 7510098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of myelin basic protein levels with receiver operating characteristic curves for diagnosis of multiple sclerosis].
    Tian ZJ; Zhao XX; Li ZH; Zhang F; Cao FT; Li SM; Shao M; Dong YX
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):250-2. PubMed ID: 19246291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of immunoreactive myelin basic protein peptide in urine of persons with multiple sclerosis.
    Whitaker JN
    Ann Neurol; 1987 Nov; 22(5):648-55. PubMed ID: 2447826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of clinical features and findings on cranial magnetic resonance imaging with urinary myelin basic protein-like material in patients with multiple sclerosis.
    Whitaker JN; Williams PH; Layton BA; McFarland HF; Stone LA; Smith ME; Kachelhofer RD; Bradley EL; Burgard S; Zhao G
    Ann Neurol; 1994 May; 35(5):577-85. PubMed ID: 7513981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment.
    Whitaker JN; Layton BA; Herman PK; Kachelhofer RD; Burgard S; Bartolucci AA
    Ann Neurol; 1993 Jan; 33(1):10-7. PubMed ID: 7684211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid levels of myelin basic protein and creatin kinase BB as index of active demyelination.
    Matias-Guiu J; Martinez-Vazquez JM; Ruibal A; Codina A
    Acta Neurol Scand; 1986 Feb; 73(2):203-7. PubMed ID: 2422866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.